[
covishield news
]Latest from covishield
How dangerous is FLiRT? 5 things about new Covid-19 variant spreading in US
In the wake of waning immunity and social distancing no longer a norm, it's important to stay alert against the new Covid threat. Here're key facts about FLiRT.

Published on May 10, 2024 01:29 PM IST
Parmita Uniyal, New Delhi
Covishield side effects: Doctors' group urges govt to review all Covid vaccines
At a press conference, the doctors, under the banner of the Awaken India Movement (AIM), urged the government to review the science behind all Covid vaccines.

Published on May 10, 2024 11:32 AM IST
PTI | | Posted by Parmita Uniyal, New Delhi
Covishield rolled back; should those jabbed with it need to worry?
After AstraZeneca withdraws Covishield, should those who took the vaccine be worried about its potential side effects on health? We asked a few experts.

Updated on May 10, 2024 11:27 AM IST
Parmita Uniyal, New Delhi
All Covishield side-effects were disclosed: Serum Institute of India
Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.

Updated on May 09, 2024 04:10 AM IST
‘Disclosed all rare side effects’: SII clarifies amid vaccine safety row
In India, the Serum Institute of India (SII) said it stopped the manufacturing of additional doses of Covishield since December 2021.

Published on May 08, 2024 07:55 PM IST
Stopped manufacturing Covishield since December 2021, says Serum Institute
The Serum Institute of India said with India achieving high vaccination rates in 2021 and 2022, coupled with the emergence of new mutant variant strains, the demand for previous vaccines diminished significantly

Updated on May 08, 2024 06:47 PM IST
AstraZeneca to withdraw Covid vaccine worldwide amid safety issues: Report
AstraZeneca states the move is due to a “surplus of available updated vaccines” since the Covid-19 pandemic.

Updated on May 08, 2024 08:18 AM IST
Written by Manjiri Chitre | Edited by Aniruddha Dhar
Afternoon briefing: Delhi Police's ‘fake msgs’ warning
The shortlist of biggest headlines, recommended stories, and special collection of news items you should check out.

Published on May 02, 2024 01:25 PM IST
Parents sue Serum Institute over daughter's death, allegedly due to Covishield
Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’

Published on May 02, 2024 11:19 AM IST
HT News Desk, New Delhi
Lawyer files plea in SC for probe into side effects of Covishield
The plea said a medical expert panel be constituted under the supervision of a former Supreme Court judge to look into the matter

Published on May 01, 2024 03:52 PM IST
'Bigger crime than violating MCC': Akhilesh Yadav on Covishield row
AstraZeneca recently admitted that its Covid vaccines ‘Covishield’ and ‘Vaxzevria’ can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS).

Published on May 01, 2024 03:22 PM IST
Fact Check: Are Covishield-vaccinated Indians susceptible to developing TTS?
AstraZeneca accepted in a legal submission that their Covid vaccine Covishield can cause Thrombosis with Thrombocytopenia Syndrome.

Updated on May 01, 2024 11:39 AM IST
Experts brush off concerns over Covid jab’s side effects
The AstraZeneca vaccine Vaxzevria was administered in India under the brand name Covishield and manufactured by the Serum Institute of India (SII)

Updated on May 01, 2024 05:56 AM IST
Rhythma Kaul, New Delhi
Covishield's rare side effect: What is Thrombosis Thrombocytopenia Syndrome?
AstraZeneca (AZ) has admitted its Covid vaccine may cause Thrombosis with Thrombocytopenia Syndrome (TTS). Know all about the rare side effect.

Published on Apr 30, 2024 06:17 PM IST
Parmita Uniyal, New Delhi
First ever comparative study reveals that Covishield outperformed Covaxin
The study was carried out by a group of 11 institutes, led by scientists from the National Centre for Biological Sciences.

Updated on Mar 08, 2024 07:26 AM IST
Learning from Covid-19 vaccination experience
The Covid-19 vaccination experience has opened a plethora of possibilities for adult vaccination

Published on Dec 02, 2023 12:30 AM IST
HC restrains 2 influencers from posting defamatory content against SII, Covishield
The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.

Updated on Jun 06, 2023 01:03 AM IST
Intranasal Covid-19 vaccine sees low response on Day 1
Mumbai's rollout of the intranasal Covid-19 vaccine saw a low response on the first day with only 23 senior citizens taking the booster dose. The vaccine, iNCOVACC by Bharat Biotech, will be administered to those above the age of 60 and eligible six months after their second dose of either Covishield or Covaxin. The state health department recently procured 2 lakh doses, of which BMC procured around 2,000 doses. The vaccine will be given through spot registration at 24 centres across Mumbai.

Updated on Apr 28, 2023 11:53 PM IST
Poor response to booster dose in Pune as vaccination resumes
PMC health officials since April 1 ran out of vaccine stock and were waiting for the vaccine supply. The civic body this week received 512 doses of the nasal vaccine iNCOVACC

Updated on Apr 28, 2023 11:51 PM IST
Few takers for booster jabs as Covid-19 cases decline in Bihar
The state reported 179 fresh cases on Wednesday. The daily new cases have been declining since April 22 when the state reported the month’s highest single-day spike of 198 infections

Updated on Apr 28, 2023 08:14 PM IST
BMC to roll out intranasal Covid vaccine for senior citizens
The vaccination drive will take place in 24 centres – one in every civic ward – across the city. The vaccine will be given through spot registration and addresses of all the locations will be posted daily on BMC’S Twitter account.

Updated on Apr 28, 2023 12:34 AM IST
Serum Institute of India to produce 5mn Covishield doses in two months
SII has made available five to six million Covovax doses even as the demand for it is still almost zero. We will produce the same amount of Covishield doses in the next two to three months, said Adar Poonawalla

Updated on Apr 22, 2023 11:01 PM IST
WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
SII chief Adar Poonawalla on Saturday said that the current Covid strain is not severe and the company has produced five to six million doses of Covovax.

Published on Apr 22, 2023 03:08 PM IST
Spike in cases prompts Maharashtra to seek 0.2mn Covid vaccine from Centre
Amidst the surge in Covid-19 cases in the state and vaccine shortage, Maharashtra government has sought 0.2 million Covid vaccine doses from the Centre

Updated on Apr 14, 2023 01:48 AM IST
Studies show XBB.1.16 is not clinically more severe
According to government data, XBB.1.16 is driving the current Covid-19 surge across the country, with at least 50% of the genome sequenced samples testing positive for it.

Updated on Apr 13, 2023 12:21 AM IST
Ludhiana hospitals run out of vaccine as Covid cases rise, last jab given on March 28
Government as well as major private hospitals across Ludhiana, including Dayanand Medical College and Hosptial (DMCH), Apollo hospital and Christian Medical College (CMC) are facing shortage of vaccine stock

Updated on Apr 12, 2023 11:56 PM IST
, Ludhiana
Dinkle PopliIndia's Serum Institute resumes Covishield production as Covid cases surge
SII CEO Adar Poonawalla says Covishield manufacturing has resumed, 6M Covovax booster doses ready, and manufacturers are ready but no demand yet.

Published on Apr 12, 2023 05:38 PM IST
PTI | | Posted by Animesh Chaturvedi
Covovax to be available on CoWIN as booster dose soon. Check details
Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.

Published on Apr 10, 2023 05:00 PM IST
PTI |
Bihar’s unmet demand of vaccine goes up with Covid cases
Over 3.49 crore precautionary doses or as many people are still to take their precautionary dose among the 5.9 crore adult population in the state, said health officials.

Updated on Apr 09, 2023 10:34 PM IST
Amid Covid surge, Tricity short of vaccine doses
Since April 1, residents of Chandigarh have been unable to receive the Covid-19 vaccine as stock ended by March 31. The local health department has reached out to the Government of India for additional vaccine supplies, but there is currently no information on when the fresh stock will arrive.

Updated on Apr 09, 2023 02:05 AM IST
, Chandigarh
Robert Abraham